Health Ministry Mandates Prescription For All Medicinal Syrups In Safety Drive

The Union Ministry of Health and Family Welfare has implemented a major regulatory shift by removing cough syrups and other syrup-based medicinal formulations from Schedule K of the Drugs Rules, 1945. This notification, effective from June 9, 2026, mandates that these products must now be sold exclusively through licensed pharmacies with a valid doctor’s prescription. By revoking the exemption that previously allowed retail establishments in smaller villages and towns to sell these medicines without formal licensing, the government aims to tighten control over the distribution of syrup formulations across India.

This move addresses persistent concerns regarding the misuse of cough syrups, which have been frequently exploited as substitutes for narcotics, particularly in rural and semi-urban areas. Furthermore, the mandate responds to international and domestic health crises involving sub-par or contaminated Indian-manufactured syrups, such as those linked to toxic solvent contamination that resulted in child deaths. The All India Organisation of Chemists and Druggists (AIOCD) has welcomed the policy, noting that it will curb illicit sales and help close long-standing regulatory loopholes that allowed unauthorized entities to dispense medicine without oversight.

The immediate impact of this policy shift requires manufacturers, distributors, and pharmacists to adhere strictly to the Drugs and Cosmetics Act, 1940. While the industry supports the amendment, professional bodies are already urging a comprehensive review of the entire Schedule K framework in consultation with health experts and patient groups to further improve safety standards. Moving forward, the government must ensure that the enforcement of these rules is consistent in remote areas, where existing monitoring of prescription-only drugs remains historically lax.